An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer

NCT00215683 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
137
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ferring Pharmaceuticals